The amyloid precursor protein and its homologues: structural and functional aspects of native and pathogenic oligomerization

scientific article

The amyloid precursor protein and its homologues: structural and functional aspects of native and pathogenic oligomerization is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJCB.2011.01.017
P698PubMed publication ID21459473

P50authorBernd ReifQ38801457
Lisa M MunterQ57637372
Gerd MulthaupQ60060387
Daniela KadenQ114369010
P433issue4
P304page(s)234-239
P577publication date2011-04-02
P1433published inEuropean Journal of Cell BiologyQ1524072
P1476titleThe amyloid precursor protein and its homologues: structural and functional aspects of native and pathogenic oligomerization
P478volume91

Reverse relations

cites work (P2860)
Q48327983APLP1 and APLP2, members of the APP family of proteins, behave similarly to APP in that they associate with NMDA receptors and enhance NMDA receptor surface expression
Q36840033APP Receptor? To Be or Not To Be.
Q39164553APP-A Novel Player within the Presynaptic Active Zone Proteome.
Q34328562Altering APP proteolysis: increasing sAPPalpha production by targeting dimerization of the APP ectodomain
Q47880180Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production
Q27694782Amyloid precursor protein dimerization and synaptogenic function depend on copper binding to the growth factor-like domain
Q34141680Amyloid precursor protein is required for normal function of the rod and cone pathways in the mouse retina
Q46143639Backbone Hydrogen Bond Strengths Can Vary Widely in Transmembrane Helices.
Q41026207Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein
Q33731321Combined immunotherapy with "anti-insulin resistance" therapy as a novel therapeutic strategy against neurodegenerative diseases
Q42578574Competition between homodimerization and cholesterol binding to the C99 domain of the amyloid precursor protein
Q35569822Deletion of the amyloid precursor-like protein 1 (APLP1) enhances excitatory synaptic transmission, reduces network inhibition but does not impair synaptic plasticity in the mouse dentate gyrus.
Q40086364Dimerization leads to changes in APP (amyloid precursor protein) trafficking mediated by LRP1 and SorLA.
Q50034432Evolvability of Amyloidogenic Proteins in Human Brain
Q37180985Manduca Contactin Regulates Amyloid Precursor Protein-Dependent Neuronal Migration
Q41913198Novel zinc-binding site in the E2 domain regulates amyloid precursor-like protein 1 (APLP1) oligomerization.
Q37987025Proteomic analysis of the presynaptic active zone
Q36222842Region-Specific Differences in Amyloid Precursor Protein Expression in the Mouse Hippocampus
Q36350742Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells
Q89747430Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease
Q39135552Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences
Q37956562Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging
Q38725946Side-chain to main-chain hydrogen bonding controls the intrinsic backbone dynamics of the amyloid precursor protein transmembrane helix
Q42092456The backbone dynamics of the amyloid precursor protein transmembrane helix provides a rationale for the sequential cleavage mechanism of γ-secretase
Q53087150The cleavage domain of the amyloid precursor protein transmembrane helix does not exhibit above-average backbone dynamics.
Q42778244The type II transmembrane serine protease matriptase cleaves the amyloid precursor protein and reduces its processing to β amyloid

Search more.